Prediction of Response to Trimodality Therapy Using CT-Derived Radiomic Features in Stage III Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Jain, P. [1 ]
Ahmad, U. [2 ]
Murthy, S. [2 ]
Stephans, K. [3 ]
Khorrami, M. [4 ]
Madabhushi, A. [4 ]
Velcheti, V. [1 ]
机构：
[1] Cleveland Clin, Pepper Pike, OH USA
[2] Cleveland Clin, Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA
[3] Cleveland Clin, Radiat Oncol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
radiomics; non-small cell lung cancer; chemoradiation;
D O I：
10.1016/j.jtho.2017.09.617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 17.11
引用
收藏
页码：S1875 / S1875
页数：1
相关论文
共 50 条
  • [1] Outcomes of Bimodality and Trimodality Therapy in Patients with Stage III Non-small Cell Lung Cancer (NSCLC)
    Hope, A. J.
    Coate, L. E.
    Massey, C.
    Sacher, A.
    Barrett, K.
    Keshavjee, S.
    Darling, G.
    Leighl, N. B.
    Bezjak, A.
    Shepherd, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S505 - S505
  • [2] Patient and Institutional Predictors of Trimodality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC) in the National Cancer Database
    Sher, D. J.
    Liptay, M. J.
    Fidler, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S180 - S180
  • [3] Association Between Trimodality Therapy and Survival in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC) in the National Cancer Database
    Sher, D. J.
    Fidler, M. J.
    Liptay, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S203 - S203
  • [4] Combination of CT derived radiomic features and lymphovascular invasion status to predict disease recurrence following trimodality therapy in non-small cell lung cancer.
    Khorrami, Mohammadhadi
    Jain, Prantesh
    Khunger, Monica
    Ahmad, Usman
    Stephans, Kevin L.
    Murthy, Sudish C.
    Velcheti, Vamsidhar
    Madabhushi, Anant
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC).
    Nakajima, Erica C.
    Leal, Jeffrey P.
    Fu, Wei
    Wang, Hao
    Chaft, Jamie E.
    Hellmann, Matthew David
    Pomper, Martin
    Forde, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] PREDICTORS OF TRIMODALITY THERAPY USE AND OVERALL SURVIVAL IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC) IN THE NATIONAL CANCER DATABASE
    Fidler, Mary Jo
    Liptay, Micheal
    Bonomi, Philip
    Sher, David
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S137 - S138
  • [7] Trimodality Therapy in the Treatment of Stage IIIA Non-Small Cell Lung Cancer (NSCLC): A National Cancer Database Analysis
    Behera, Madhusmita
    Steuer, Conor
    Fernandez, Felix
    Liu, Yuan
    Fu, Chao
    Gillespie, Theresa W.
    Higgins, Kristin A.
    Saba, Nabil
    Pillai, RathiN.
    Force, Seth
    Pakkala, Suchita
    Shin, Dong
    Owonikoko, Taofeek K.
    Belani, Chandra P.
    Curran, Walter J.
    Khuri, Fadlo
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S182 - S183
  • [8] Trimodality therapy in stage III non-small cell lung cancer:: prediction of recurrence by assessment of p185neu
    Thomas, M
    Rübe, C
    Semik, M
    von Eiff, M
    Klinke, F
    Macha, HN
    Freitag, L
    Scheld, HH
    Willich, N
    Berdel, WE
    Junker, K
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (02) : 424 - 429
  • [9] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    De Ruysscher, D.
    LUNG CANCER, 2009, 64 : S21 - S21
  • [10] Trimodality treatment of Stage III non-small cell lung cancer in Western Australia
    Croker, J.
    Ariyapperuma, M.
    Sharma, S.
    Mukhedkar, S.
    Lam, W. S.
    Lim, T.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S760 - S760
12345